Scientific Session
Hematologic- and oncologic-associated rheumatic syndromes
Thomas Loughran, MD
University of Virginia
Charlottesville, VA, United States
Disclosure: Disclosure(s): DrenBio, Inc.: Consultant (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Keystone Nano, Inc.: Officer or Board Member (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Kymera Therapeutics: Consultant (Ongoing); Prime Genomics: Advisor or Review Panel Member (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Recludix Pharma, Inc.: Advisor or Review Panel Member (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing)
